Methotrexate treatment and mortality in rheumatoid arthritis

Lancet. 2002 Oct 5;360(9339):1096-7. doi: 10.1016/s0140-6736(02)11159-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / mortality
  • France / epidemiology
  • Humans
  • Lymphoma / epidemiology*
  • Lymphoma / etiology*
  • Methotrexate / adverse effects*
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Antirheumatic Agents
  • Methotrexate